Factors affecting women's selection of a combined hormonal contraceptive method: the TEAM-06 Spanish cross-sectional study

Contraception

Volumn 76, Issue 2, 2007, Pages 77-83

  Lete, Iñaki ^a   Doval, Jose Luis ^b   Pérez Campos, Ezequiel ^c   Sánchez Borrego, Rafael ^d   Correa, Marta ^e   de la Viuda, Esther ^f   Gómez, Mari Angeles ^g   González, José Vicente ^h   Lertxundi, Roberto ⁱ   Martínez, María Teresa ^f   Mendoza, Nicolás ^j   Robledo, Javier ^c  

^a HOSPITAL TXAGORRITXU   (Spain)

^b Complejo Hospitalario de Ourense ^*  (Spain)

^c HOSPITAL GENERAL DE REQUENA   (Spain)

^d Diatros   (Spain)

^e HOSPITAL UNIVERSITARIO DE CANARIAS   (Spain)

^f HOSPITAL UNIVERSITARIO DE GUADALAJARA   (Spain)

^g Family Planning Center Alicante 3   (Spain)

^h HOSPITAL CLÍNICO UNIVERSITARIO LOZANO BLESA   (Spain)

ⁱ Euskalduna Clinic   (Spain)

^j HOSPITAL UNIVERSITARIO VIRGEN DE LAS NIEVES   (Spain)

more..

Author keywords

Contraception; Contraceptive pill; Contraceptive use; Contraceptives; Hormonal; Skin patch; Vaginal ring

Indexed keywords

ORAL CONTRACEPTIVE AGENT;

ADULT; ARTICLE; CLINICAL TRIAL; FEMALE; HORMONAL CONTRACEPTION; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; OVULATION INHIBITION; PATIENT COMPLIANCE; SEXUAL BEHAVIOR; VAGINA RING;

ADMINISTRATION, CUTANEOUS; ADMINISTRATION, ORAL; ADOLESCENT; ADULT; CONTRACEPTION BEHAVIOR; CONTRACEPTIVE AGENTS, FEMALE; CONTRACEPTIVE DEVICES, FEMALE; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MIDDLE AGED; PATIENT SATISFACTION; QUESTIONNAIRES; SPAIN;

EID: 34447622837     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.contraception.2007.04.014     Document Type: Article

References (22)

1. Piccinino L.J., and Mosher W.D. Trends in contraceptive use in the United States: 1982-1995. Fam Plann Perspect 30 (1998) 4-10
2. Lete I., Bermejo R., Coll C., et al. Spanish population at risk of unwanted pregnancy: results of a national survey. Eur J Contracept Reprod Health Care 8 (2003) 75-79
3. Lete I., Bermejo R., Coll C., et al. Use of contraceptive methods in Spain: results of a national survey. Contraception 63 (2001) 235-238
4. Gallo M.F., Grimes D.A., and Schulz K.F. Skin patch and vaginal ring versus combined oral contraceptives for contraception. Cochrane Database Syst Rev 1 (2003;) CD003552
5. Herndon E.J., and Zieman M. New contraceptive options. Am Fam Physician 69 (2004) 853-860
6. Plourd D.M., and Rayburn W.F. New contraceptive methods. J Reprod Med 48 (2003) 665-671
7. Johnson L.K., Edelman A., and Jensen J. Patient satisfaction and the impact of written material about postpartum contraception decisions. Am J Obstet Gynecol 188 (2003) 1202-1204
8. Parrilla J.J., Coll C., Bajo J.M., et al. Analysis of compliance with oral contraception in Spain. Eur J Contracept Reprod Health Care 1 (1996) 337-347
9. Foran T.M. New contraceptive choices across reproductive life. Med J Aust 178 (2003) 616-620
10. Gilliam M., Knight S., and McCarthy Jr. M. Success with oral contraceptives: a pilot study. Contraception 69 (2004) 413-418
11. Rajasekar D., and Bigrigg A. Pill knowledge amongst oral contraceptive users in family planning clinics in Scotland: facts, myths and fantasies. Eur J Contracept Reprod Health Care 5 (2000) 85-90
12. Skouby S.O. Contraceptive use and behavior in the 21st century: a comprehensive study across five European countries. Eur J Contracept Reprod Health Care 9 (2004) 57-68
13. Draper L. Working women and contraception. History, health, and choices. AAOHN J 54 (2006) 317-324
14. Rosenberg M., and Waugh M.S. Causes and consequences of oral contraceptive non-compliance. Am J Obstet Gynecol 180 (1999) S276-S279
15. Milsom I., Lete I., Bjertnaes A., et al. Effects on cycle control and bodyweight of the combined contraceptive ring, NuvaRing, versus an oral contraceptive containing 30 microg ethinyl estradiol and 3 mg drospirenone. Hum Reprod 21 (2006) 2304-2311
16. Archer D.F., Cullins V., Creasy G.W., and Fisher A.C. The impact of improved compliance with a weekly contraceptive transdermal system (Ortho Evra®) on contraceptive efficacy. Contraception 69 (2004) 189-195
17. Weisberg F., Bouchard C., Moreau M., et al. Preference for and satisfaction of Canadian women with the transdermal contraceptive patch versus previous contraceptive method: an open-label, multicentre study. J Obstet Gynaecol Can 27 (2005) 350-359
18. Heger-Mahn D., Warlimont C., Faustmann T., Gerlinger C., and Klipping C. Combined ethinylestradiol/gestodene contraceptive patch: two-center, open-label study of ovulation inhibition, acceptability and safety over two cycles in female volunteers. Eur J Contracept Reprod Health Care 9 (2004) 173-181
19. Urdl W., Apter D., Alperstein A., et al. Contraceptive efficacy, compliance and beyond: factors related to satisfaction with once-weekly transdermal compared with oral contraception. Eur J Obstet Gynecol Reprod Biol 121 (2005) 202-210
20. Harel Z., Riggs S., Vaz R., Flanagan P., Dunn K., and Harel D. Adolescents' experience with the combined estrogen and progestin transdermal contraceptive method Ortho Evra. J Pediatr Adolesc Gynecol 18 (2005) 85-90
21. Roumen J.M.E., op ten Berg M.M.T., and Hoomans E.H.M. The combined contraceptive vaginal ring (NuvaRing®): first experience in daily clinical practice in The Netherlands. Eur J Contracept Reprod Health Care 11 (2006) 14-22
22. Barnhart K.T., Timbers K., Pretorius E.S., Lin K., and Shaunik A. In vivo assessment of NuvaRing placement. Contraception 72 (2005) 196-199